Showing all posts written by Catherine Gourash
Catherine Gourash is an associate in the firm’s Washington, D.C. office. Ms. Gourash’s practice focuses on patent law, with an emphasis on pharmaceutical litigation under the Hatch-Waxman Act.
Ms. Gourash joined the firm in 2014.
Click here to read full bio
The University of Twente in Enschede, Netherlands recently introduced “the world’s smallest and most accurate 3D-printed biopsy robot,” called the Stormram 4. The device is designed to carry out biopsies during breast cancer
A research team from Trinity College Dublin has recently discovered a way to reduce the incidence of medical device-associated infection resulting from biofilms. The term “biofilms” refers to organized colonies of bacteria that
biotricity, a medical diagnostic and consumer healthcare technology company, recently announced its partnership with AT&T, in which the internet service provider will serve as the preferred network to power biotricity’s wearable